By Professor Diane Ashiru PhD, Lead Pharmacist for AMR and HCAI at UKHSA and Chair of ESPAUR: ''I am pleased that the new UK adaptation of the World Health Organization's (WHO) AWaRe classification has now been published. It marks an important milestone in our nation's approach to antimicrobial stewardship. This comprehensive update, developed through a modified Delphi-style consensus process, represents a unified approach across all 4 nations of the UK, replacing previous nation-specific adaptations.''
Leading health experts and environmental advocates united to address one of the most pressing global health challenges: AMR. In a groundbreaking webinar, the Instituto de Defensa de Consumidores (IDEC), Brazil and ReAct Latin America presented a new policy brief outlining strategic recommendations to address this growing global health challenge.
The increasing global crisis of antibiotic resistance demands urgent and multi-faceted solutions, yet a less recognised driver of resistance is pollution from antibiotic production. Waste from manufacturing sites can create hotspots of resistance, disproportionately affecting low- and middle-income countries. This policy brief addresses the intersection of environmental pollution, antibiotic resistance, and equitable access to antibiotics, offering practical recommendations for systemic change.
The ReAct Africa Youth Report, compiled by ReAct Africa with support from the Swedish International Development Agency (SIDA), evaluates the effectiveness of ReAct Africa’s youth initiatives in addressing AMR in sub-Saharan Africa.
Tamil Nadu’s new One Health and Climate Change Hub aims to tackle antimicrobial resistance (AMR) by integrating strategies across health, agriculture, environment, and more.
Launched in November 2024, it emphasises cross-sector collaboration, political commitment, and actionable solutions.
The initiative seeks to strengthen AMR’s role in public health and climate resilience efforts, with a focus on coordinated governance, data-driven policies, and public-private partnerships.
The group brings together parliamentarians with extensive and varied professional backgrounds, all passionate about combating AMR.
1.7AMR Resource Pack 2025. Resource Pack published by World Health Organisation on 20 January.
The 2025 AMR Resource Pack provides useful resources for the development and implementation of national action plans (NAPs) on AMR. In this version, the documents are now listed following the core package of 13 AMR interventions of the "People-centred approach to addressing antimicrobial resistance in human health: WHO core package of interventions to support national action plans". The people-centred interventions can be used as a basis to prioritise and select activities to be included in NAPs on AMR following a programmatic approach that considers the challenges and health system barriers people face when accessing health services as well as the interdependencies between AMR interventions.
2. Journal content
2.1 Journal of Medical Microbiology | Volume 73, Issue 11, 2024:
With 2024 now behind us with all its elevated attention to antibiotic resistance, 2025 lies in front of us as a fork in the road where action and the momentum from last year’s High Level Meeting, will either continue to grow – or - priorities will have moved on and actions will stagnate. ReAct of course hopes for the first option, but also deems is necessary to be prepared to work hard to prevent that antibiotic resistance does not fall completely off the radar of politicians again.
The article reflects on a meeting held at the National University of Loja, Ecuador on 2 December 2024 with the participation of more than 50 students from the Faculty of Human Health, teachers, and university authorities.
This event, organised in collaboration with ReAct, focused on the role of microorganisms in sustaining life and the challenges associated with bacterial resistance, under the "Mother Earth One Health" approach.
When Pte Oleksander Bezverkhny was evacuated to the Feofaniya Hospital in Kyiv, few believed he would live. The 27-year-old had a severe abdominal injury and shrapnel had ripped through his buttocks. Both his legs were amputated.
A new report from the Fleming Initiative and Google DeepMind lays out a vision for the impact that an AI and data-driven approach to one of the world’s biggest health challenges might have.
This workshop aimed to bring together a wide range of stakeholders from academia, industry, government, and non-profit organisations to facilitate discussions on combatting AMR through innovative solutions and strategies.
4.2 The Global Leaders Group on AMR hosted an information session to provide inputs and guidance to the Quadripartite organisations on the process, consultations, and timelines for the establishment of the Independent Panel on Evidence for Action against AMR on 30 January.
The International Centre for Antimicrobial Resistance Solutions (ICARS) co-organised the side-meeting, with the AMR Multi-Stakeholder Partnership Platform and the International Health Policy Programme.
ICARS published a news article about the side-meeting.
The Prince Mahidol Award Conference (PMAC) 2025 Side-Meeting, “Bridging Policy and Action – A Post-UNGA One Health Agenda for AMR,” took place at the Centara Grand and Bangkok Convention Centre in Bangkok, Thailand. Organised by the International Centre for Antimicrobial Resistance Solutions (ICARS), the AMR Multi-Stakeholder Partnership Platform (AMR MSPP), and the International Health Policy Programme (IHPP). The event brought together regional and national experts, policymakers, civil society and other stakeholders to discuss Antimicrobial Resistance (AMR) in the Asia-Pacific region. Building upon the momentum from the 2024 United Nations General Assembly (UNGA) High-Level Meeting on AMR, the event focused on translating global commitments into actions and practical solutions to mitigate AMR in the region.
4.4Action on Antimicrobial Resistance. Session hosted at the World Economic Forum Annual Meeting in Davos-Klosters, Switzerland on 23 January.
Antimicrobial resistance (AMR), often termed the "silent pandemic", is exacerbated by market failures in the development of new antibiotics and is projected to cost the global economy up to $100 trillion by 2050. This crisis is driven by insufficient incentives for the pharmaceutical industry, from low sales volumes to uncertain returns on investment. How can innovative financing models be leveraged to close this gap and preserve life-saving medicines?
This session was accompanied by the AMR Davos Declaration and the launch of a Unified Coalition for the AMR Response (UCARES), focusing on sustainable financing for antibiotics. Speakers: Mads Krogsgaard Thomsen, Sally Davies, Michael Sen, Orazio Schillaci, Magdalena Skipper.
